167 related articles for article (PubMed ID: 23918341)
21. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.
Zhang F; Huang X; Zhu L; Guo N; Niu G; Swierczewska M; Lee S; Xu H; Wang AY; Mohamedali KA; Rosenblum MG; Lu G; Chen X
Biomaterials; 2012 Jul; 33(21):5414-22. PubMed ID: 22560667
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle-based multimodal PET/MRI probes.
Garcia J; Tang T; Louie AY
Nanomedicine (Lond); 2015; 10(8):1343-59. PubMed ID: 25955127
[TBL] [Abstract][Full Text] [Related]
24. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.
Karageorgou MA; Vranješ-Djurić S; Radović M; Lyberopoulou A; Antić B; Rouchota M; Gazouli M; Loudos G; Xanthopoulos S; Sideratou Z; Stamopoulos D; Bouziotis P; Tsoukalas C
Contrast Media Mol Imaging; 2017; 2017():6951240. PubMed ID: 29445321
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging.
Fernández-Barahona I; Ruiz-Cabello J; Herranz F; Pellico J
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531725
[TBL] [Abstract][Full Text] [Related]
26. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z
J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048
[TBL] [Abstract][Full Text] [Related]
29. Preliminary studies of
Lahooti A; Shanehsazzadeh S; Laurent S
Nanotechnology; 2020 Jan; 31(1):015102. PubMed ID: 31519003
[TBL] [Abstract][Full Text] [Related]
30. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
[TBL] [Abstract][Full Text] [Related]
31. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
32. Relaxation Properties of Contrast Media for MRI Based on Iron Oxide Nanoparticles in Different Magnetic Fields.
Chekhonin VP; Abakumov MA; Mazhuga AG; Bagdinova AN; Demikhov EI; Demikhov TE; Mishkinis BY; Konstantinov MV; Tarasov VP; Shumm BA; Gippius AA; Gervits NV; Shumm AB
Bull Exp Biol Med; 2019 May; 167(1):97-99. PubMed ID: 31183644
[TBL] [Abstract][Full Text] [Related]
33. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
34. Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging.
Sharma R; Xu Y; Kim SW; Schueller MJ; Alexoff D; Smith SD; Wang W; Schlyer D
Nanoscale; 2013 Aug; 5(16):7476-83. PubMed ID: 23832243
[TBL] [Abstract][Full Text] [Related]
35. Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging.
Cui X; Belo S; Krüger D; Yan Y; de Rosales RT; Jauregui-Osoro M; Ye H; Su S; Mathe D; Kovács N; Horváth I; Semjeni M; Sunassee K; Szigeti K; Green MA; Blower PJ
Biomaterials; 2014 Jul; 35(22):5840-6. PubMed ID: 24768194
[TBL] [Abstract][Full Text] [Related]
36. Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.
Im HJ; England CG; Feng L; Graves SA; Hernandez R; Nickles RJ; Liu Z; Lee DS; Cho SY; Cai W
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17955-63. PubMed ID: 27340833
[TBL] [Abstract][Full Text] [Related]
37. Magnetic nanoparticle assisted molecular MR imaging.
Jun YW; Jang JT; Cheon J
Adv Exp Med Biol; 2007; 620():85-106. PubMed ID: 18217337
[TBL] [Abstract][Full Text] [Related]
38. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging.
Jarzyna PA; Skajaa T; Gianella A; Cormode DP; Samber DD; Dickson SD; Chen W; Griffioen AW; Fayad ZA; Mulder WJ
Biomaterials; 2009 Dec; 30(36):6947-54. PubMed ID: 19783295
[TBL] [Abstract][Full Text] [Related]
39. Surface ligand-regulated renal clearance of MRI/SPECT dual-modality nanoprobes for tumor imaging.
Chen C; Huang B; Zhang R; Sun C; Chen L; Ge J; Zhou D; Li Y; Wu S; Qian Z; Zeng J; Gao M
J Nanobiotechnology; 2024 May; 22(1):245. PubMed ID: 38735921
[TBL] [Abstract][Full Text] [Related]
40. Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging.
Yang M; Cheng K; Qi S; Liu H; Jiang Y; Jiang H; Li J; Chen K; Zhang H; Cheng Z
Biomaterials; 2013 Apr; 34(11):2796-806. PubMed ID: 23343632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
